Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease

NCT00219284 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

359

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease With End of Dose Wearing Off

Interventions

DRUG: Carbidopa/levodopa/entacapone

Sponsor

Novartis Pharmaceuticals